Skip to main content

What are the early signs of multiple sclerosis?

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 8, 2024.

Official answer

by Drugs.com

Some of the early signs of multiple sclerosis (MS) include weakness or numbness in one or more limbs; tremor or abnormal, uncoordinated movements while walking; slurred speech, or dizziness; double vision or the painful loss of vision in one eye; or long-lasting fatigue.

Most symptoms develop abruptly, within hours or days, reach their peak within a few days, and resolve slowly lasting for about 8 weeks from onset to recovery.

But just because you have some of these symptoms doesn’t necessarily mean you have MS. Other conditions that can resemble MS symptoms or affect myelin include:

  • Viral infections
  • Collagen vascular disease
  • Exposure to toxic materials
  • Guillain-Barré syndrome
  • Severe vitamin B-12 deficiency
  • Rare heredity disorders
  • Other autoimmune disorders.
References
  • Rolak LA. Multiple sclerosis: it's not the disease you thought it was. Clin Med Res. 2003;1(1):57-60. doi:10.3121/cmr.1.1.57
  • Multiple sclerosis Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

Read next

How long can you live with multiple sclerosis?

Multiple sclerosis (MS) is not generally considered life-threatening and most people will live a normal life-span. One study has found that the average life expectancy for people with MS is 76 years of age. In 2019, the U.S. life-expectancy averaged 78.8 years, but in 2020 it declined to 77.3 years, primarily due to the COVID pandemic. Many people with MS may live for 25 to 35 years or longer after their diagnosis. Continue reading

Prednisone: What are 12 Things You Should Know?

Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading

Is Kesimpta better than Ocrevus?

In patients with relapsing forms of multiple sclerosis, Kesimpta (ofatumumab) is thought to be more effective than Ocrevus (ocrelizumab) in some ways, but no clinical trials have directly compared the two drugs

Ocrevus is the only one of the two drugs approved to treat primary progressive multiple sclerosis Continue reading

Related medical questions

Related support groups